Exercise as an Immune Adjuvant for Allogeneic Cell Therapies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies — Stella

Recruiting

Back to Leukemia trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

The University of Arizona, Tucson, Arizona

Key details

Phase

Very early testing

Sponsor

University of Arizona

Collaborators

National Cancer Institute (NCI)

Enrollment target

~100 participants

Started

January 2018

Primary completion

December 2028

Age range

21 Years – 55 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov